Featured New York Vein Treatment Center

Glow Aesthetics and Surgery, Glow Medispa
Glow Aesthetics and Surgery, Glow Medispa
One Expressway Plaza
Suite 115
Roslyn Heights NY 11577

Phone: (866) 418-1453
Email | Map
Contact Glow Aesthetics and Surgery, Glow Medispa
Hours:

Mon-Fri: 10 - 8 Sat-Sun: 11-4 by appointment Evenings by special request



About Glow Aesthetics and Surgery, Glow Medispa

Sofia Rubbani, MD, FACS, graduated from New York University School of Medicine. She completed her residency at NYU where she was given the honor of Chief Resident in her final year of training. Dr. Rubbani was trained and served as Chief Resident at Manhattan Eye Ear and Throat Hospital on the Upper East Side, which is Manhattan's premier cosmetic surgery hospital. She is Board Certified and very excited to provide you with the best in cosmetic procedures and treatments.

Health News

Eliminate Varicose Veins with Invisible Veins, a Product of Pharmaco LLC

Berkshire Information Systems, Inc., (Berkshire) a leading provider of e-commerce fulfillment solutions through e2e-store, announced the launch of their newest e-commerce site with Pharmaco LLC. Pharmaco LLC is the supplier of Invisible Veins, a vascular support product and dietary supplement.

New York City Skin Care Leader Juva Skin Introduces HarmonyXL for Treatment of 60-plus Skin Applications

HarmonyXL could be the answer to the prayers of consumers who seek less invasive skin rejuvenation. The multi-functional device's antiaging secret is its combination of light- and laser-based treatment approaches, which targets a variety of skin concerns and types with less post-treatment recovery time. The skin treatment innovation is now available to patients of Manhattan's Juva Skin and Laser Center.

VNUS Medical Technologies to Present at UBS Global Life Sciences Conference

SAN JOSE, Calif., Sept. 16 /PRNewswire-FirstCall/ -- VNUS(R) Medical Technologies, Inc. (Nasdaq: VNUS), a leading provider of medical devices for the minimally invasive treatment of venous reflux disease, today announced its plans to present at the UBS Global Life Sciences Conference, to be held September 22-25, 2008, at the Grand Hyatt Hotel in New York City.

338 Patient Pivotal Trial Demonstrates Safety and Effectiveness of Polidocanol Sclerotherapy Product for Varicose Vein Treatment

SAN MATEO, Calif., Sept. 4 /PRNewswire-FirstCall/ -- BioForm Medical, Inc. (Nasdaq: BFRM) today announced that the pivotal clinical study of Polidocanol, conducted in Germany by BioForm Medical's partner, Chemische Fabrik KREUSSLER & Co. GmbH (Kreussler), successfully met the study primary endpoint and has been submitted to FDA as part of a New Drug Application (NDA) process.